Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Ton Schumacher

Principal Investigator

Oncode Institute

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (13)

Tiantian Liu

Assistant Professor

Scripps Research Institute

UNITED STATES

View details

Alma Dupanovic

St. Anna Children's Cancer Research Institute

AUSTRIA

View details

Nienke van Rooij

University Medical Center Groningen

NETHERLANDS

View details

Jeffrey Ward

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Danielle C Pappas

UNITED STATES

View details

Matthias Leisegang

Associate Professor

Otto-von-Guericke Universität Magdeburg

GERMANY

View details

Kabir Khan

University of Toronto

CANADA

View details

Manfred Lehner

St. Anna Children's Cancer Research Institute

AUSTRIA

View details

Noel de Miranda

Professor

Leiden University Medical Center

NETHERLANDS

View details

Olga Isaeva

Antoni van Leeuwenhoek Nederlands Kanker Instituut

NETHERLANDS

View details

Jeanette Leusen

professor

University Medical Center Groningen

NETHERLANDS

View details

Hannah Garner

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

NETHERLANDS

View details

Simone Brioschi

Assistant Professor

The University of Texas Health Science Center at Houston

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ton Schumacher

Research Interests

Explore related searches

Articles (20)

Natural Killer Cell–Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell Leukemia

Properties of CD8 T-cell-recognized neoantigens in different tumor types

Immunological Tolerance to Luciferase and Fluorescent Proteins Using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis

Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening

Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies

Learning the language of T cell receptors through large-scale screening

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

ITPK1 Sensitizes Tumor Cells to IgA-dependent Neutrophil Killing In Vivo

IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity

Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system.

CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool

DNA damage induces p53-independent apoptosis through ribosome stalling

Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironment

Erratum: Gene and protein sequence features augment HLA class I ligand predictions (Cell Reports (2024) 43(6), (S2211124724006533), (10.1016/j.celrep.2024.114325))

Gene and protein sequence features augment HLA class I ligand predictions

Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial

Collaborators (13)

Tiantian Liu

Alma Dupanovic

Nienke van Rooij

Jeffrey Ward

Danielle C Pappas

Matthias Leisegang

Kabir Khan

Manfred Lehner

Noel de Miranda

Olga Isaeva

Jeanette Leusen

Hannah Garner

Simone Brioschi

Make your next move.